Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Phase III Open Label Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face
Authors not listed
Biolab Sanus Farmaceutica · 2009
Abstract
The purpose of this study is to determinate whether Xeomin® (Botulinum toxin Type A) is safe, effective and tolerable in woman aged 30 to 50 years old for treatment of mild, moderate or severe expression lines (wrinkles) in the upper third of the face. The main outcome was the change in appearance of the wrinkles two weeks (visit 3) after product application as compared with baseline assessment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Anonymous. (2009). Phase III Open Label Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face. <em>Biolab Sanus Farmaceutica</em>. https://clinicaltrials.gov/study/NCT00986570
Vancouver
Anonymous. Phase III Open Label Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face. Biolab Sanus Farmaceutica. 2009.
BibTeX
@misc{anon2009PhaseI,
title = {Phase III Open Label Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face},
author = {Anonymous},
journal = {Biolab Sanus Farmaceutica},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Revance Therapeutics, Inc. 2013
Open access · US-GOV
Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Heidelberg University 2006
Open access · US-GOV
A Monocentric, Randomized, Controlled Trial to Test the Efficacy of Interferon-beta in the Treatment of Disseminated Encephalomyelitis (ED)-Associated and Primary Intermediate Uveitis in Comparison to Standard Treatment (TEAM)
Meridigen Biotech Co., Ltd. 2021
Open access · US-GOV
A Phase I, Open Label, Dose Escalation Study to Evaluate the Safety and Tolerability After Intravenous Infusion of UMC119-06-05 in Elderly Subjects With Mild to Moderate Frailty Syndrome.
Chinese Academy of Medical Sciences 2021
Open access · US-GOV
A Randomized, Double-Blinded, Placebo Controlled Phase III Clinical Trial of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in Adults Aged 18 Years and Above
Revance Therapeutics, Inc. 2015
Open access · US-GOV
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
Sinovac Research and Development Co., Ltd. 2023
Open access · US-GOV